Climate Health Pharma

First confirmed case of avian influenza in mammals found in sub-Antarctica 

HQ Team January 16, 2024: The government of South Georgia and the South Sandwich Islands has detected avian influenza in mammals for the.

Read More
Drugs Health Medical

Global deaths from fungal disease double, account for 6.8% of overall

HQ team January 16, 2024: A recent study has found that global deaths from fungal diseases have doubled in the past decade. The.

Read More
Drugs Health Pharma

Opinion: Vaccine for malaria took a while, but it’s worth the wait

By K. Leelamoni January 16, 2024: Vaccination is a simple, safe and effective method of protecting the body against infectious diseases. Ever since.

Read More
Climate Health Medical

‘100,000 Afghani kids face a bleak future amidst strife and temblors’

HQ Team January 16, 2024: Over 96,000 children in Afghanistan are in dire need of support almost 100 days after earthquakes devastated the.

Read More
Drugs Health Pharma

University of Oxford starts human trials to develop vaccine against Nipah virus 

HQ Team January 11, 2023: The first human trials for a vaccine against Nipah virus have been started by the University of Oxford,.

Read More
Drugs Health Pharma

GSK Plc., to buy asthma drugmaker Aiolos Bio for $1.4 billion  

HQ Team January 9, 2023: British drugmaker GSK Plc., will pay $1.4 billion to acquire Anglo-American biopharmaceutical company  Aiolos Bio Inc., which makes.

Read More
Drugs Health Pharma

Novo Nordisk diabetes drug meets trial goals against insulin glargine

 HQ Team January 9, 2023: Denmark’s Novo Nordisk declared its late-stage experimental once-weekly diabetes drug IcoSema achieved its primary endpoint of proving “non-inferiority” in.

Read More
Drugs Health Pharma

Merck to buy Harpoon for $680 million to step up cancer portfolio

HQ Team January 8, 2024: Merck & Co., will acquire Harpoon Therapeutics, Inc., for $680 million to expand its cancer drug portfolio —.

Read More
Drugs Health Pharma

J&J to purchase Ambrx Biopharma for $2 billion in all-cash deal

HQ Team January 8, 2023: Johnson & Johnson will buy Ambrx Biopharma, Inc., a company developing targeted chemotherapy treatments, for $2 billion in cash..

Read More
Drugs Health Pharma

Antimalarial drug may have killed 17,000 people in first Covid-19 wave

HQ Team January 8, 2024: About 17,000 people may have died in six countries after using antimalarial drug hydroxychloroquine during the first wave.

Read More